Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Growing Menance of HPV-related Throat and Mouth Cancers

February 8, 2016 11:46 am | by Dalhousie University | News | Comments

There's a new cancer epidemic on the rise. It's an aggressive throat and mouth cancer caused by the human papillomavirus (HPV)—the same sexually transmitted virus that leads to cervical cancer—but it's affecting mostly men in the prime of their lives. Read more...


Muscles On-a-Chip Provide Insight into Cardiac Stem Cell Therapies

February 8, 2016 11:39 am | News | Comments

Stem cell-derived heart muscle cells may fail to effectively replace damaged cardiac tissue because they don't contract strongly enough, according to a study in The Journal of Cell Biology. Read more...


White House Seeks $1.8B to Battle Zika Virus

February 8, 2016 10:32 am | by Ryan Bushey, Associate Editor | News | Comments

Funds will be allocated toward three departments to support a slew of programs. Read more...


Testing New Method of Rapid Detection of Wound Infection

February 8, 2016 10:16 am | by George Washington University | News | Comments

A new method for detection of infection in wounds could take physicians less than a minute to complete, rather than the current 24 hours it takes to plate bacteria and leave it to incubate overnight, according to research by the George Washington University's (GW) Victoria Shanmugam, M.D. Read more..


Proteomics and Precision Medicine

February 8, 2016 10:09 am | by University of Iowa | News | Comments

As medical professionals search for new ways to personalize diagnosis and treatment of disease, a research team at the University of Iowa has already put into practice what may be the next big step in precision medicine: personalized proteomics. Read more...


FDA Investigates Stem Cell Clinics Selling Suspicious Treatments

February 8, 2016 9:56 am | by Ryan Bushey, Associate Editor | News | Comments

The Food and Drug Administration launched a plan today to crack down on stem cell clinics claiming they offer treatments for a variety of diseases, with questionable proof. Read more...


Brazil Considers Reforming Biosecurity Law Amid Criticism

February 8, 2016 8:22 am | by Jenny Barchfield and Mauricio Savarese, Associated Press | News | Comments

Brazilian officials will soon decide whether to amend the South American nation's rigid procedures for sharing Zika samples. Read more...


Mersana, Takeda Expand Partnership to Advance Development of Antibody Drug Conjugates

February 8, 2016 8:18 am | News | Comments

XMT-1522 is an investigational, Fleximer-based ADC therapy that targets HER2-expressing tumors. Read more...


Karolinska University to Investigate Stem-Cell Scientist

February 8, 2016 8:13 am | by The Associated Press | News | Comments

Sweden's Karolinska University said it is commissioning an external investigation into stem-cell scientist Paolo Macchiarini. Read more...


First MERS Autopsy Reveals Critical Information

February 8, 2016 8:10 am | by Seth Augenstein, Digital Reporter | News | Comments

Ebola and now Zika are two viruses that have monopolized headlines for two years. But the Middle East respiratory syndrome is a potentially deadly contagion also on the radar of health officials worldwide. Read more...


Australia's Painkiller Use Increased Four-Fold in 10 Years

February 8, 2016 8:05 am | by University of New South Wales | News | Comments

Researchers say cancer-related pain in the ageing population and chronic pain have driven a 400 percent increase in the use of common opioid painkillers in Australia over the past decade. Read more...


Why It's Wrong to Compare Zika to Ebola

February 8, 2016 8:04 am | by Clare Wenham, London School of Economics and Political Science, The Conversation | News | Comments

Only one in five of those infected experiences flu like symptoms, which rarely require hospitalization. Read more...


FDA Rejects Expanded Use of Vertex Cystic Fibrosis Drug

February 5, 2016 11:10 am | by Reuters | News | Comments

The U.S. Food and Drug Administration has denied the expanded use of Vertex Pharmaceutical Inc's bestseller, Kalydeco, in certain cystic fibrosis patients, the company said on Friday. Read more..


Dogs Could Accelerate Advance of New Cancer Treatments for Both Pets and People

February 5, 2016 11:05 am | by The Translational Genomics Research Institute | News | Comments

Science Translational Medicine review suggests integrating dogs with naturally occurring cancers into studies of new drug therapeutics could result in better treatments for our four-legged friends while helping inform therapeutic development for human cancers. Read more...


Blincyto Phase 3 Study Met Primary Endpoint of OS In Patients With B-Cell Precursor ALL

February 5, 2016 10:43 am | News | Comments

Amgen today announced that the results of a prespecified interim analysis showed that the primary endpoint of improved overall survival was met in the Phase 3 TOWER study. The randomized, open-label TOWER study evaluated the efficacy of Blincyto (blinatumomab) versus standard of care (SOC) in adult patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).  Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.